back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-07-04 12:18 Tx date 2023-06-30 |
$HLS
HLS Therapeutics Inc. |
Athyrium Opportunities II Co-Invest 1 LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,507,500
-1,300,000 vol $5.78 each |
3,051,782 | |
| Filed 2020-01-17 21:16 Tx date 2020-01-15 |
$HLS
HLS Therapeutics Inc. |
Athyrium Opportunities II Co-Invest 1 LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+226,782 vol |
4,351,782 | |
| Filed 2020-01-17 21:16 Tx date 2020-01-15 |
$HLS
HLS Therapeutics Inc. |
Athyrium Opportunities II Co-Invest 1 LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-525,409 vol |
0 | |
| Filed 2018-03-15 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Athyrium Opportunities II Co-Invest 1 LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-15 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Athyrium Opportunities II Co-Invest 1 LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-15 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Athyrium Opportunities II Co-Invest 1 LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+4,125,000 vol |
4,125,000 | |
| Filed 2018-03-15 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Athyrium Opportunities II Co-Invest 1 LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-15 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Athyrium Opportunities II Co-Invest 1 LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+525,409 vol |
525,409 | |
| Filed 2018-03-15 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Athyrium Opportunities II Co-Invest 1 LP
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|